title: [Peculiarities of upper urinary tract drainage during surgical treatment of staghorn and multiple nephrolithiasis].
abstract: This work was designed to evaluate methods of kidney drainage used in the surgical treatment of 250 patients with staghorn and multiple nephrolithiasis (SMN). All of them underwent open surgery that was followed by drainage of the upper urinary tract in 192 patients. Internal stenting was used in 111 cases, pyelostomy in 28, nephrostomy in 47, and internal stenting with nephrostoma in 6 cases. 91 and 20 patients had a stent inserted into the upper urinary tract in a retrograde and antegrade manner respectively. Retrograde stenting was bilateral in 14 and unilateral in 66 cases. 85% of the cases with ureter stents were followed up as outpatients for 4-5 weeks and only 10% for 6-7 weeks. Forty and ten patients with stents presented with marked dysuria and hematuria respectively. On the whole, combined antibacterial treatment with drainage of the upper urinary tract significantly improved long-term results of SMN treatment. It is concluded that nephrostomy and pyelostomy should be performed on days 14-18 and 10-12 respectively whereas the stent needs to be removed between weeks 2 and 8 after surgery.
authors.forename: S B
authors.initials: SB
authors.lastname: Imamverdiev
authors.forename: T A
authors.initials: TA
authors.lastname: Talybov
authors.forename: R N
authors.initials: RN
authors.lastname: Mamedov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D004322:Drainage / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D053040:Nephrolithiasis / Q000145:classification / Q000188:drug therapy / Q000601:surgery*; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome; D014551:Urinary Tract / Q000601:surgery*; D013520:Urologic Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*
chemical_list: D000900:Anti-Bacterial Agents